324 related articles for article (PubMed ID: 62946)
21. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
22. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
23. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
[TBL] [Abstract][Full Text] [Related]
24. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
[No Abstract] [Full Text] [Related]
25. Short course chemotherapy for lymph node tuberculosis: final report at 5 years. British Thoracic Society Research Committee.
Br J Dis Chest; 1988 Jul; 82(3):282-4. PubMed ID: 3073808
[TBL] [Abstract][Full Text] [Related]
26. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
[TBL] [Abstract][Full Text] [Related]
27. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
[TBL] [Abstract][Full Text] [Related]
28. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Lancet; 1974 Nov; 2(7889):1100-6. PubMed ID: 4139405
[No Abstract] [Full Text] [Related]
29. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. First report of 4th study. East African and British Medical Research Councils.
Lancet; 1978 Aug; 2(8085):334-8. PubMed ID: 79708
[TBL] [Abstract][Full Text] [Related]
30. Two phase chemotherapy with streptomycin isoniazid and ethambutol, followed by isoniazid and ethambutol.
Purohit SD; Sharma GS; Bomb BS
J Assoc Physicians India; 1975 Jun; 23(6):385-9. PubMed ID: 1184566
[No Abstract] [Full Text] [Related]
31. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.
Jindani A; Nunn AJ; Enarson DA
Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185
[TBL] [Abstract][Full Text] [Related]
32. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Virsik K; Kruty R; Matula F; Badalik L
Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
[No Abstract] [Full Text] [Related]
33. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
Chioléro R
Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
[No Abstract] [Full Text] [Related]
34. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association.
Br J Dis Chest; 1981 Apr; 75(2):141-53. PubMed ID: 7023526
[TBL] [Abstract][Full Text] [Related]
35. [Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
Wada M; Yoshiyama T; Ogata H; Ito K; Mizutani S; Sugita H
Kekkaku; 1999 Apr; 74(4):353-60. PubMed ID: 10355221
[TBL] [Abstract][Full Text] [Related]
36. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
37. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
38. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
Bobarykin VS
Probl Tuberk; 1991; (10):53-5. PubMed ID: 1788233
[No Abstract] [Full Text] [Related]
39. High-dose ethambutol: its role in intermittent chemotherapy. A six-year study.
Albert RK; Sbarbaro JA; Hudson LD; Iseman M
Am Rev Respir Dis; 1976 Oct; 114(4):699-704. PubMed ID: 970746
[TBL] [Abstract][Full Text] [Related]
40. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
Balasubramanian R; Nagarajan M; Balambal R; Tripathy SP; Sundararaman R; Venkatesan P; Paramasivam CN; Rajasambandam P; Rangabashyam N; Prabhakar R
Int J Tuberc Lung Dis; 1997 Feb; 1(1):44-51. PubMed ID: 9441058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
